Calcium entry and vascular smooth muscle excitation
钙进入和血管平滑肌兴奋
基本信息
- 批准号:6891569
- 负责人:
- 金额:$ 33.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-06-01 至 2007-05-31
- 项目状态:已结题
- 来源:
- 关键词:antisense nucleic acidarginine vasopressincalcium channelcalcium fluxcalcium indicatorcell lineimmunocytochemistryinositol phosphateslaboratory ratmembrane channelsmembrane potentialspolymerase chain reactionprotein structure functionsarcoplasmic reticulumtransfectionvascular smooth musclevasoconstrictionvoltage /patch clampvoltage gated channelwestern blottings
项目摘要
DESCRIPTION (provided by applicant): Vasoconstrictor hormones cause contraction of vascular smooth muscle (VSM) cells by increasing cytosolic free Ca2+ concentration ([Ca2+]i). The best characterized signal transduction pathway leading to elevation of [Ca2+]i involves inositol trisphosphate-mediated release of Ca2+ from the sarcoplasmic reticulum (SR) and Ca2+ entry via non-selective calcium-permeable cation channels. Voltage-sensitive L-type Ca2+ channels are also known to be important in vasoconstrictor action, though the signaling pathways leading to activation of L-type channels are not well characterized. We have previously demonstrated that physiological concentrations of [Arg8]-vasopressin (AVP, 10-100 pM) induce Ca2+ spiking in A7r5 VSM cells by a novel signaling pathway that leads to activation of L-type Ca2+ channels. Membrane depolarization is presumably required for L-type Ca2+ channel activation. We hypothesize, that AVP exerts a depolarizing effect on the smooth muscle cells. Among the most likely candidates to elicit this effect are non-selective cation channels. We have previously provided evidence for two distinct non-L-type divalent cation entry pathways activated by AVP. The molecular natures of the channels that mediate these effects are not known, but members of the transient receptor potential (TRP) family of non-selective cation channels have been implicated. The present proposal seeks to examine the hypothesis that these divalent cation entry pathways play an important role in the Ca2+ spiking response to physiological AVP concentrations. The specific aims are to: 1) identify which TRP channel homologues are expressed in A7r5 cells and rat mesenteric artery smooth muscle cells (RMASMC) using RT-PCR and Western blotting; 2) characterize the non-selective cation currents activated by 100 pM AVP in A7r5 cells and RMASMC and evaluate their contribution to membrane potential changes using patch clamp techniques; 3) dissociate "capacitative" store-operated Ca2+ entry from non-capacitative AVP-stimulated Ca2+ entry pathways and determine which is/are important in triggering Ca2+ spiking; 4) knock out or overexpress specific TRP channel homologues to determine their role in AVP-stimulated Ca2+ signaling and their relationship to AVP-stimulated nonselective cation currents and Ca2+ entry pathways.
描述(由申请人提供):血管收缩激素通过增加胞质游离Ca2+浓度([Ca2+]i)引起血管平滑肌(VSM)细胞的收缩。导致[Ca2+]i升高的最具特征的信号转导途径涉及肌醇三磷酸介导的Ca2+从肌浆网(SR)释放和Ca2+通过非选择性钙透性阳离子通道进入。电压敏感的l型Ca2+通道在血管收缩作用中也很重要,尽管导致l型通道激活的信号通路尚未得到很好的表征。我们之前已经证明,生理浓度的[Arg8]-抗利尿激素(AVP, 10-100 pM)通过一种新的信号通路,导致l型Ca2+通道的激活,诱导A7r5 VSM细胞中的Ca2+峰值。膜去极化可能是l型Ca2+通道激活所必需的。我们推测,AVP对平滑肌细胞有去极化作用。最有可能引起这种效应的候选者是非选择性阳离子通道。我们之前已经提供了AVP激活的两种不同的非l型二价阳离子进入途径的证据。介导这些作用的通道的分子性质尚不清楚,但非选择性阳离子通道的瞬时受体电位(TRP)家族成员已被牵连。目前的建议旨在检查这些二价阳离子进入途径在生理AVP浓度的Ca2+尖峰反应中起重要作用的假设。具体目的是:1)利用RT-PCR和Western blotting鉴定在A7r5细胞和大鼠肠系膜动脉平滑肌细胞(RMASMC)中表达哪些TRP通道同源物;2)利用膜片钳技术表征100 pM AVP在A7r5细胞和RMASMC中激活的非选择性阳离子电流,并评估其对膜电位变化的贡献;3)从非容性avp刺激的Ca2+进入途径中分离出“容性”存储操作的Ca2+进入途径,并确定哪些是触发Ca2+尖峰的重要途径;4)敲除或过表达特异性TRP通道同源物,以确定它们在avp刺激的Ca2+信号传导中的作用,以及它们与avp刺激的非选择性阳离子电流和Ca2+进入途径的关系。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KENNETH L BYRON其他文献
KENNETH L BYRON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KENNETH L BYRON', 18)}}的其他基金
KCNQ Channels in Airway Smooth Muscle Physiology and Disease
KCNQ 气道平滑肌生理学和疾病中的通道
- 批准号:
9210531 - 财政年份:2016
- 资助金额:
$ 33.3万 - 项目类别:
KCNQ Channels and Vasoconstrictor Signal Transduction
KCNQ 通道和血管收缩信号转导
- 批准号:
7758181 - 财政年份:2009
- 资助金额:
$ 33.3万 - 项目类别:
KCNQ Channels and Vasoconstrictor Signal Transduction
KCNQ 通道和血管收缩信号转导
- 批准号:
8024529 - 财政年份:2009
- 资助金额:
$ 33.3万 - 项目类别:
KCNQ Channels and Vasoconstrictor Signal Transduction
KCNQ 通道和血管收缩信号转导
- 批准号:
8403740 - 财政年份:2009
- 资助金额:
$ 33.3万 - 项目类别:
KCNQ Channels and Vasoconstrictor Signal Transduction
KCNQ 通道和血管收缩信号转导
- 批准号:
7582000 - 财政年份:2009
- 资助金额:
$ 33.3万 - 项目类别:
KCNQ Channels and Vasoconstrictor Signal Transduction
KCNQ 通道和血管收缩信号转导
- 批准号:
8206590 - 财政年份:2009
- 资助金额:
$ 33.3万 - 项目类别:
Calcium entry and vascular smooth muscle excitation
钙进入和血管平滑肌兴奋
- 批准号:
6609587 - 财政年份:2003
- 资助金额:
$ 33.3万 - 项目类别:
Calcium entry and vascular smooth muscle excitation
钙进入和血管平滑肌兴奋
- 批准号:
7058719 - 财政年份:2003
- 资助金额:
$ 33.3万 - 项目类别:
Calcium entry and vascular smooth muscle excitation
钙进入和血管平滑肌兴奋
- 批准号:
6749575 - 财政年份:2003
- 资助金额:
$ 33.3万 - 项目类别:
SIGNALING BY VASOPRESSIN--ARTERIAL SMOOTH MUSCLE CELLS
加压素发出的信号——动脉平滑肌细胞
- 批准号:
6184234 - 财政年份:1999
- 资助金额:
$ 33.3万 - 项目类别:
相似海外基金
PET ligand discovery for arginine vasopressin
精氨酸加压素的 PET 配体发现
- 批准号:
10641669 - 财政年份:2022
- 资助金额:
$ 33.3万 - 项目类别:
PET ligand discovery for arginine vasopressin
精氨酸加压素的 PET 配体发现
- 批准号:
10356395 - 财政年份:2022
- 资助金额:
$ 33.3万 - 项目类别:
Role of arginine-vasopressin and V1A receptor in psychosocial stress-induced myocardial injury
精氨酸加压素和 V1A 受体在心理应激诱发的心肌损伤中的作用
- 批准号:
10671052 - 财政年份:2021
- 资助金额:
$ 33.3万 - 项目类别:
Role of arginine-vasopressin and V1A receptor in psychosocial stress-induced myocardial injury
精氨酸加压素和 V1A 受体在心理应激诱发的心肌损伤中的作用
- 批准号:
10283131 - 财政年份:2021
- 资助金额:
$ 33.3万 - 项目类别:
Role of arginine-vasopressin and V1A receptor in psychosocial stress-induced myocardial injury
精氨酸加压素和 V1A 受体在心理应激诱发的心肌损伤中的作用
- 批准号:
10470346 - 财政年份:2021
- 资助金额:
$ 33.3万 - 项目类别:
Physiological role of arginine vasopressin released from RGCs on circadian rhythm and psychiatry function
RGC 释放的精氨酸加压素对昼夜节律和精神功能的生理作用
- 批准号:
19K06939 - 财政年份:2019
- 资助金额:
$ 33.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of mechanisms of arginine vasopressin receptor 1A in peripheral neuropathic pain
精氨酸加压素受体 1A 在周围神经病理性疼痛中的作用机制的鉴定
- 批准号:
18K16609 - 财政年份:2018
- 资助金额:
$ 33.3万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Functional mapping of arginine vasopressin receptor 1A circuits that promote anorexic behavior
促进厌食行为的精氨酸加压素受体 1A 电路的功能图谱
- 批准号:
10321547 - 财政年份:2018
- 资助金额:
$ 33.3万 - 项目类别:
Usefulness of arginine vasopressin levels on admission in risk stratification of acute decompensated heart failure with preserved left ventricular ejection fraction
入院时精氨酸加压素水平在左心室射血分数保留的急性失代偿性心力衰竭风险分层中的作用
- 批准号:
16K09448 - 财政年份:2016
- 资助金额:
$ 33.3万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Variation in the arginine vasopressin 1a receptor (AVPR1a) gene, the social environment, general health and wellbeing
精氨酸加压素 1a 受体 (AVPR1a) 基因的变异、社会环境、总体健康和福祉
- 批准号:
DP130100612 - 财政年份:2013
- 资助金额:
$ 33.3万 - 项目类别:
Discovery Projects














{{item.name}}会员




